Monte Rosa Therapeutics, Inc. (GLUE)
13.78
-0.52
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
13.77
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics 1 Year Total Returns (Daily) : 185.8% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 185.8% |
| August 21, 2026 | 217.8% |
| August 20, 2026 | 233.6% |
| August 19, 2026 | 258.4% |
| August 18, 2026 | 229.6% |
| August 17, 2026 | 235.8% |
| August 14, 2026 | 256.3% |
| August 13, 2026 | 256.8% |
| August 12, 2026 | 258.4% |
| August 11, 2026 | 276.1% |
| August 10, 2026 | 261.2% |
| August 07, 2026 | 275.4% |
| August 06, 2026 | 260.7% |
| August 05, 2026 | 223.2% |
| August 04, 2026 | 229.5% |
| August 03, 2026 | 221.1% |
| July 31, 2026 | 233.7% |
| July 30, 2026 | 306.5% |
| July 29, 2026 | 309.9% |
| July 28, 2026 | 297.1% |
| July 27, 2026 | 297.9% |
| July 24, 2026 | 298.9% |
| July 23, 2026 | 286.4% |
| July 22, 2026 | 320.3% |
| July 21, 2026 | 305.3% |
| Date | Value |
|---|---|
| July 20, 2026 | 295.3% |
| July 17, 2026 | 316.3% |
| July 16, 2026 | 312.8% |
| July 15, 2026 | 347.6% |
| July 14, 2026 | 346.0% |
| July 13, 2026 | 326.0% |
| July 10, 2026 | 338.0% |
| July 09, 2026 | 363.5% |
| July 08, 2026 | 375.5% |
| July 07, 2026 | 390.9% |
| July 06, 2026 | 377.4% |
| July 02, 2026 | 411.8% |
| July 01, 2026 | 421.0% |
| June 30, 2026 | 436.6% |
| June 29, 2026 | 419.6% |
| June 26, 2026 | 378.3% |
| June 25, 2026 | 354.1% |
| June 24, 2026 | 339.9% |
| June 23, 2026 | 346.3% |
| June 22, 2026 | 303.2% |
| June 18, 2026 | 307.8% |
| June 17, 2026 | 302.8% |
| June 16, 2026 | 268.5% |
| June 15, 2026 | 269.0% |
| June 12, 2026 | 270.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Nurix Therapeutics, Inc. | 159.1% |
| Gilead Sciences, Inc. | 31.20% |
| Ironwood Pharmaceuticals, Inc. | 225.2% |
| Capricor Therapeutics, Inc. | -4.23% |
| Cue Biopharma, Inc. | -6.46% |